Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Panic disorder as presenting symptoms of multiple sclerosis.
Multiple sclerosis in children.
Measurement characteristics and clinical utility of the 29-item Multiple Sclerosis Impact Scale.
A novel association of ocular neuromyotonia with brainstem demyelination: Two case reports.
Standing Data Disproves Biomechanical Mechanism for Balance-Based Torso-Weighting.
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patients.
The gateway theory: bridging neural and immune interactions in the CNS.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
A methylenetetrahydrofolate reductase gene polymorphism in multiple sclerosis.
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
L-periaxin interacts with S-periaxin through its PDZ domain.
Guillain-Barre syndrome following dengue fever and literature review.
[Demyelinating diseases in children with acute neurological symptoms].
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Towards Clinical Application of Mesenchymal Stem Cells for Treatment of Neurological Diseases of the Central Nervous System.
Twenty years of experience on stem cell transplantation in iran.
In vivo quantification of demyelination and recovery using compartment-specific diffusion MRI metrics validated by electron microscopy.
Modeling the course and outcomes of multiple sclerosis is statistical twaddle-Yes.
Clinical response and tolerability of fampridine in clinical practice.
Complement in neurobiology.
Multiple Sclerosis and Experimental Allergic Encephalomyelitis.
The contribution of assessing cognitive impairment in radiologically-isolated syndrome (RIS): A single case report follow-up study.
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Pages
« first
‹ previous
…
585
586
587
588
589
590
591
592
593
…
next ›
last »